Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Bionomics Ltd.
DescriptionActivator of nicotinic acetylcholine receptor alpha 7 (CHRNA7)
Molecular Target Nicotinic acetylcholine receptor alpha 7 (CHRNA7)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today